Target intelligence / Profile preview

Allantoicase (ALLC)

Target
ALLC
Molecular classification
Enzyme, Hydrolase (acts on carbon-nitrogen bonds other than peptide bonds, specifically linear amidines)
01

Overview

Allantoicase is an enzyme (systematic name: allantoate amidinohydrolase, EC 3.5.3.4) that catalyzes the hydrolysis of allantoate to (S)-ureidoglycolate and urea, as part of the purine degradation pathway. It belongs to the hydrolase family, specifically acting on carbon-nitrogen bonds in linear amidines. The enzyme is hexameric (dimer of trimers), with each subunit showing a jelly-roll beta-sheet motif, and the active site is formed by conserved surface patches at the interface of these motifs[1][2][4][5][7]. While important for nitrogen recycling in plants, microorganisms, fish, and amphibians, the human genome encodes a homolog (ALLC) that appears to be functionally inactive; thus, there is no established role for human disease or as a therapeutic target[1][6]. No drugs or biomarkers are currently associated with allantoicase, and there are no known safety concerns.

Other names
Allantoate amidinohydrolaseALCprobable inactive allantoicaseputative inactive allantoicaseallantoicase (EC 3.5.3.4)
02

Biological functions

Purine degradation (catalyzes the conversion of allantoate to ureidoglycolate and urea, a step in the uricolytic pathway)Nitrogen metabolism (facilitates nitrogen utilization from purines, especially under nitrogen-limiting conditions)
03

Disease associations

Other (no direct, well-established role in human disease described; in humans, the gene is present but appears to have lost function)

Beyond the preview

Go deeper on Allantoicase (ALLC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allantoicase (ALLC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call